KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Total Non-Current Liabilities: 2018-2025

Historic Total Non-Current Liabilities for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $1.5 billion.

  • Guardant Health's Total Non-Current Liabilities rose 1.82% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1.82%. This contributed to the annual value of $1.5 billion for FY2024, which is 0.05% up from last year.
  • Guardant Health's Total Non-Current Liabilities amounted to $1.5 billion in Q3 2025, which was down 0.61% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Total Non-Current Liabilities registered a high of $1.6 billion during Q1 2022, and its lowest value of $1.4 billion during Q1 2021.
  • Moreover, its 3-year median value for Total Non-Current Liabilities was $1.5 billion (2025), whereas its average is $1.5 billion.
  • As far as peak fluctuations go, Guardant Health's Total Non-Current Liabilities surged by 1,201.66% in 2021, and later fell by 3.17% in 2024.
  • Over the past 5 years, Guardant Health's Total Non-Current Liabilities (Quarterly) stood at $1.6 billion in 2021, then dropped by 0.96% to $1.5 billion in 2022, then dropped by 0.58% to $1.5 billion in 2023, then grew by 0.05% to $1.5 billion in 2024, then climbed by 1.82% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.5 billion for Q2 2025, and $1.5 billion during Q1 2025.